×
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
S&P 500   3,978.73
DOW   32,120.28
QQQ   291.26
NASDAQ:CABA

Cabaletta Bio Earnings Date, Estimates, & History

$1.28
0.00 (0.00%)
(As of 05/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.24
$1.39
50-Day Range
$1.22
$2.29
52-Week Range
$1.17
$14.95
Volume
38,018 shs
Average Volume
166,890 shs
Market Capitalization
$37.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.53

Earnings Summary

Upcoming
Earnings Date
Aug. 4Estimated
Actual EPS
(May. 12)
-$0.45 Beat By $0.08
Consensus EPS
(May. 12)
-$0.53
Skip Charts & View Estimated and Actual Earnings Data

Cabaletta Bio Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Cabaletta Bio Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cabaletta Bio (NASDAQ:CABA) Earnings Estimates

Current Year EPS Consensus Estimate: $-2.07 EPS
Next Year EPS Consensus Estimate: $-2.23 EPS

CABA Earnings Information

Cabaletta Bio last released its earnings data on May 12th, 2022. The reported ($0.45) EPS for the quarter, topping analysts' consensus estimates of ($0.53) by $0.08. Cabaletta Bio has generated ($1.84) earnings per share over the last year (($1.84) diluted earnings per share). Earnings for Cabaletta Bio are expected to decrease in the coming year, from ($2.07) to ($2.23) per share. Cabaletta Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off prior year's report dates.

Cabaletta Bio (NASDAQ:CABA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/4/2022
(Estimated)
        
5/12/20223/31/2022($0.53)($0.45)+$0.08    
3/17/2022Q4 2021($0.68)($0.49)+$0.19($0.49)
10/31/20219/30/2021($0.50)($0.45)+$0.05($0.45)
8/5/20216/30/2021($0.48)($0.45)+$0.03($0.45)
5/2/20213/31/2021($0.46)($0.41)+$0.05($0.41)
3/15/202112/31/2020($0.38)($0.40)($0.02)($0.40)
11/15/20209/30/2020($0.44)($0.36)+$0.08($0.36)  
8/6/20206/30/2020($0.39)($0.35)+$0.04($0.35)
5/12/20203/31/2020($0.23)($0.33)($0.10)($0.33)
3/30/202012/31/2019($0.65)($0.33)+$0.32($0.33)
(Earnings results data provided by Zacks Investment Research)












Cabaletta Bio (NASDAQ:CABA) Earnings Frequently Asked Questions

When is Cabaletta Bio's earnings date?

Cabaletta Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 4th, 2022 based off last year's report dates. Learn more on CABA's earnings history.

Did Cabaletta Bio beat their earnings estimates last quarter?

In the previous quarter, Cabaletta Bio (NASDAQ:CABA) reported ($0.45) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.53) by $0.08. Learn more on analysts' earnings estimate vs. CABA's actual earnings.

How can I listen to Cabaletta Bio's earnings conference call?

The conference call for Cabaletta Bio's latest earnings report can be listened to online. Listen to Conference Call

How can I read Cabaletta Bio's conference call transcript?

The conference call transcript for Cabaletta Bio's latest earnings report can be read online. Read Transcript

How much profit does Cabaletta Bio generate each year?

Cabaletta Bio (NASDAQ:CABA) has a recorded net income of -$46.29 million. CABA has generated -$1.84 earnings per share over the last four quarters.

What is Cabaletta Bio's EPS forecast for next year?

Cabaletta Bio's earnings are expected to decrease from ($2.07) per share to ($2.23) per share in the next year.

This page was last updated on 5/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.